CureVac N.V. (CVAC) Establishes Subsidiary to Advance The RNA Printer(R
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer(R)
March 1, 2022 7:17 AM ESTThe RNA Printer(R) is CureVac's integrated and automated manufacturing solution for RNA vaccines and therapeuticsCureVac RNA Printer GmbH to provide dedicated infrastructure to accelerate development and broaden application range of The RNA Printer(R)Dr. Markus Bergmann appointed as General Manager for CureVac RNA Printer GmbH
TBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / March 1, 2022 / CureVac N.V. (NASDAQ: CVAC), a global biopharmaceutical company... More
